ProShare Advisors’s Regenxbio RGNX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$94.2K Sell
11,468
-835
-7% -$6.86K ﹤0.01% 1889
2025
Q1
$88K Sell
12,303
-3,011
-20% -$21.5K ﹤0.01% 1866
2024
Q4
$118K Buy
15,314
+2,800
+22% +$21.6K ﹤0.01% 2039
2024
Q3
$131K Buy
+12,514
New +$131K ﹤0.01% 1839
2024
Q2
Sell
-11,384
Closed -$240K 1970
2024
Q1
$240K Buy
11,384
+874
+8% +$18.4K ﹤0.01% 1565
2023
Q4
$189K Buy
+10,510
New +$189K ﹤0.01% 1653
2023
Q1
Sell
-9,847
Closed -$223K 1888
2022
Q4
$223K Buy
9,847
+758
+8% +$17.2K ﹤0.01% 1418
2022
Q3
$240K Buy
9,089
+129
+1% +$3.41K ﹤0.01% 1283
2022
Q2
$221K Sell
8,960
-4,177
-32% -$103K ﹤0.01% 1408
2022
Q1
$436K Sell
13,137
-2,691
-17% -$89.3K ﹤0.01% 1370
2021
Q4
$518K Buy
15,828
+703
+5% +$23K ﹤0.01% 1414
2021
Q3
$634K Sell
15,125
-3,699
-20% -$155K ﹤0.01% 1073
2021
Q2
$731K Buy
18,824
+1,602
+9% +$62.2K ﹤0.01% 1246
2021
Q1
$587K Buy
17,222
+3,334
+24% +$114K ﹤0.01% 1329
2020
Q4
$630K Buy
13,888
+3,158
+29% +$143K ﹤0.01% 1128
2020
Q3
$295K Sell
10,730
-380
-3% -$10.4K ﹤0.01% 1189
2020
Q2
$409K Buy
11,110
+3,570
+47% +$131K ﹤0.01% 1055
2020
Q1
$244K Sell
7,540
-5,818
-44% -$188K ﹤0.01% 939
2019
Q4
$547K Sell
13,358
-1,200
-8% -$49.1K ﹤0.01% 1023
2019
Q3
$518K Sell
14,558
-411
-3% -$14.6K ﹤0.01% 971
2019
Q2
$769K Sell
14,969
-1,770
-11% -$90.9K ﹤0.01% 859
2019
Q1
$959K Buy
16,739
+366
+2% +$21K 0.01% 778
2018
Q4
$687K Sell
16,373
-2,684
-14% -$113K ﹤0.01% 828
2018
Q3
$1.44M Buy
19,057
+1,005
+6% +$75.9K 0.01% 681
2018
Q2
$1.3M Buy
18,052
+95
+0.5% +$6.82K 0.01% 743
2018
Q1
$536K Sell
17,957
-2,908
-14% -$86.8K ﹤0.01% 1068
2017
Q4
$694K Buy
20,865
+1,572
+8% +$52.3K ﹤0.01% 983
2017
Q3
$636K Buy
19,293
+1,041
+6% +$34.3K 0.01% 876
2017
Q2
$360K Buy
18,252
+1,790
+11% +$35.3K ﹤0.01% 1079
2017
Q1
$318K Sell
16,462
-4,282
-21% -$82.7K ﹤0.01% 1213
2016
Q4
$385K Buy
+20,744
New +$385K ﹤0.01% 1222